Most Read Articles
Elaine Soliven, 27 Sep 2017
A second dose of kisspeptin-54 improves oocyte yield in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) treatment, according to a recent study.
23 Oct 2017
Pearl Toh spoke with Dr Teh Ming Ming, senior consultant at the Department of Endocrinology, Singapore General Hospital (SGH), on the major challenges of diagnosing and managing diabetes in primary care, in conjunction with the World Diabetes Day on 14 November. Awareness of the symptoms of diabetes is important, and patients should be empowered to manage their conditions.
Rachel Soon, 2 days ago

Pharmacists can and should utilize their positions within communities to provide access to an extended range of healthcare services, says an expert.

01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

D-cycloserine may have insignificant benefits to OCD, AD

17 Mar 2017
One in three Malaysians suffer from mental health problems

D-cycloserine (DCS), used to augment behaviour therapy in patients with obsessive-compulsive (OCD) and anxiety disorders (AD), may have very little to almost no effect, a new meta-analysis reveals.

Web of Science, PubMed, PsychArticles, Psyndex and PsycInfo were accessed for this meta-analysis. Only randomized, placebo-controlled, double-blinded studies that examined the effect of DCS interventions on cognitive behavioural therapy (CBT) on human patients with anxiety and obsessive-compulsive disorders were included.

The methodological qualities and risk of bias of the studies selected were evaluated using a self-developed scale based on the method of the Cochrane Collaboration.

The search resulted in 23 studies corresponding to a cumulative sample size of 1,314 patients (659 received DCS, 655 were controls). The mean quality score of the studies was 8.4 (range, 6.5 to 10).

The Hedge’s g estimates, which do not take into account pretreatment values, showed that DCS had no effect on CBT for mid-treatment (g, -0.12; 95 percent CI, -0.28 to 0.07; p=0.14) and only a small effect post-treatment (g, -0.12; -0.47 to -0.08; p<0.01).

On the other hand, the standardized mean change score (SMCC), which controls for the pretreatment values, showed that DCS had no significant effect during mid-treatment (SMCC, -0.05; -0.26 to 0.15; p=0.31), post-treatment (SMCC, -0.10; -0.29 to 0.07; p=0.13) and a 1-month follow-up (SMCC, -0.18; -0.46 to 0.10; p=0.10).

Despite previous meta-analyses finding DCS to yield moderate improvements, the most recent studies indicate that this may actually be insignificant. Primary studies of higher quality are needed to avoid overestimation of the benefits and effects of such interventions.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacy - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elaine Soliven, 27 Sep 2017
A second dose of kisspeptin-54 improves oocyte yield in women at high risk of ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) treatment, according to a recent study.
23 Oct 2017
Pearl Toh spoke with Dr Teh Ming Ming, senior consultant at the Department of Endocrinology, Singapore General Hospital (SGH), on the major challenges of diagnosing and managing diabetes in primary care, in conjunction with the World Diabetes Day on 14 November. Awareness of the symptoms of diabetes is important, and patients should be empowered to manage their conditions.
Rachel Soon, 2 days ago

Pharmacists can and should utilize their positions within communities to provide access to an extended range of healthcare services, says an expert.

01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.